Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
Hall S, Danby R, Osman H, Peniket A, Rocha V, Craddock C, Murphy M, Chaganti S. Hall S, et al. Among authors: chaganti s. Transfus Med. 2015 Dec;25(6):418-23. doi: 10.1111/tme.12219. Epub 2015 Jun 26. Transfus Med. 2015. PMID: 26114211
Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Chaganti S, Malladi R, Parker A, Craddock C, Danby R, Rocha V. Brierley CK, et al. Among authors: chaganti s. Br J Haematol. 2019 Feb;184(4):547-557. doi: 10.1111/bjh.15685. Epub 2018 Nov 22. Br J Haematol. 2019. PMID: 30467838 Free article. Clinical Trial.
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.
Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S. Fox CP, et al. Among authors: chaganti s. Bone Marrow Transplant. 2014 Feb;49(2):280-6. doi: 10.1038/bmt.2013.170. Epub 2013 Nov 11. Bone Marrow Transplant. 2014. PMID: 24212561
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant.
Nikolousis E, Robinson S, Nagra S, Brookes C, Kinsella F, Tauro S, Jeffries S, Griffiths M, Mahendra P, Cook M, Paneesha S, Lovell R, Kishore B, Chaganti S, Malladi R, Raghavan M, Moss P, Milligan D, Craddock C. Nikolousis E, et al. Among authors: chaganti s. Leuk Res. 2013 May;37(5):561-5. doi: 10.1016/j.leukres.2013.01.010. Epub 2013 Feb 5. Leuk Res. 2013. PMID: 23395505 Clinical Trial.
Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.
Hounsome L, Eyre TA, Ireland R, Hodson A, Walewska R, Ardeshna K, Chaganti S, McKay P, Davies A, Fox CP, Kalakonda N, Fields PA. Hounsome L, et al. Among authors: chaganti s. Br J Cancer. 2022 Jan;126(1):134-143. doi: 10.1038/s41416-021-01525-4. Epub 2021 Oct 5. Br J Cancer. 2022. PMID: 34611308 Free PMC article.
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
Roddie C, Sandhu KS, Tholouli E, Logan AC, Shaughnessy P, Barba P, Ghobadi A, Guerreiro M, Yallop D, Abedi M, Pantin JM, Yared JA, Beitinjaneh AM, Chaganti S, Hodby K, Menne T, Arellano ML, Malladi R, Shah BD, Mountjoy L, O'Dwyer KM, Peggs KS, Lao-Sirieix P, Zhang Y, Brugger W, Braendle E, Pule M, Bishop MR, DeAngelo DJ, Park JH, Jabbour E. Roddie C, et al. Among authors: chaganti s. N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2406526. Online ahead of print. N Engl J Med. 2024. PMID: 39602653
Diel metatranscriptomes capture cyanobacteria-dominated Lake Erie community response to episodic events.
Zepernick BN, Boegehold AG, Kiledal EA, Chase EE, Hart LN, Houghton KA, Martin RM, Williams PA, Johnson EC, Schofield PK, Cory RM, Chaganti SR, Godwin CM, Spanbauer TL, Dick GJ, Errera RM, Wilhelm SW. Zepernick BN, et al. Among authors: chaganti sr. Microbiol Resour Announc. 2024 Nov 12;13(11):e0065924. doi: 10.1128/mra.00659-24. Epub 2024 Oct 4. Microbiol Resour Announc. 2024. PMID: 39365054 Free PMC article.
160 results